Ask us about our all new nutritional supplement focused on heart health as well as blood sugar support.
To find out more, email us at Tersus@Tersuspharma.com.
All New Nutritional Supplement For Heart Health & Blood Sugar Support – LIPPOA™
Palmitoleic acid: An omega-7 fatty acid for inflammation & metabolic wellness
Although the omega-3, -6, -7 and -9 category of fatty acids has grown consistently over the past few decades—and the worldwide market for fatty acids will grow from nearly $13.5 billion in 2018 to $17.5 billion by 20231—the public and the dietary supplement industry know the least about the value of the omega-7 fatty acids. This article will explain the value of an extremely well-researched omega-7 fatty acid, palmitoleic acid. https://tersuslifesciences.com/wp-content/uploads/2022/10/2.-Palmitoleic-acid-An-omega-7-fatty-acid-for-inflammation-metabolic-wellness-2.pdf
“Atherosclerosis and Purified Omega 7”
In this 4-minute video, Dr. Michael F. Roizen, Chairman of the Wellness Institute of The Cleveland Clinic, talks about atherosclerosis, its causes and consequences: heart disease, stroke, memory loss, impotence, and wrinkling.
Dr. Roizen shares how purified Omega 7 (palmitoleic acid) may potentially help in the fight against diabetes, metabolic syndrome, and atherosclerosis. This is exciting news because Purified Omega 7 “antagonizes” all three because it has been shown to decrease insulin resistance, decrease hepatic fat accumulation, and decrease acute and chronic inflammation – with no known side effects.
To conclude, Dr. Roizen puts all into perspective: Purified Omega 7 could have a huge benefit for our populations as a whole because metabolic syndrome, insulin resistance, and diabetes are big things we need to tackle for us to be more competitive for jobs, and the United States to be more competitive as a society.”
“A medical breakthrough you should know about”
By Drs. Oz & Roizen, the “You Docs” (Excerpted from “Four Medical Breakthroughs you should know about”)
Recently, we were totally blown away by four medical breakthroughs we think you should know about.
Purified Omega 7
The “new” good fat: You’ve already heard plenty about DHA, the great-for-you omega-3 fatty acid in fatty fish and algae or fish-oil capsules. Now, research from Harvard Medical School, the Cleveland Clinic (where Dr. Mike is Chief Wellness Officer) and universities in Hawaii and Japan revealed that [Omega-7 fatty acids found in purified palmitoleic acid have amazing powers too!
Our take: Take 200 milligrams of purified omega-7 in capsule form along with 900 milligrams of DHA daily.
Published in the Houston Chronicle on Friday, July 20, 2012
Image of Dr. Michael Roizen used with permission of Dr. Michael Roizen.
Dr. Michael Roizen is the Author of Real Age, Chairman Chief Wellness Officer of Cleveland Clinic, and Chairman of Scientific Advisory Board of Tersus Pharmaceuticals.
Diabetes forecast to hit one in 10 adults by 2030
(Reuters) – One in 10 adults will have diabetes by 2030, posing a huge challenge to healthcare systems around the world, according to a report on Monday.
The number of people living with the disease is expected to soar to 552 million by 2030 — equating to three new cases every 10 seconds — up from 366 million in 2011, unless urgent action is taken, the International Diabetes Federation said.
The vast majority of diabetics have Type 2 disease — the kind linked to poor diet, obesity and lack of exercise — and the problem is spreading as people in the developing world adopt more Western lifestyles.
Diabetics have inadequate blood sugar control, which can lead to serious complications like heart disease and stroke, damage to the kidneys or nerves, and to blindness. Worldwide deaths from the disease are now running at 4.6 million a year.
“In every country and in every community worldwide, we are losing the battle against this cruel and deadly disease,” said Jean Claude Mbanya, president of the federation, which represents over 200 national associations.
Many older classes of diabetes drugs are now available as cheap generics, but global drugmakers — including Sanofi, Eli Lilly and Novo Nordisk — aim to introduce new classes of drugs that could further extend treatment options.
Global sales of diabetes medicines totaled $35 billion last year and could rise to as much as $48 billion by 2015, according to research firm IMS Health, driven by increased prevalence and treatment, especially in countries such as China, India, Mexico and Brazil.
(Reporting by Ben Hirschler; Editing by Jon Loades-Carter)
Source: Reuters